or
1-Naphthothienylalkyl-1H-imidazoles



Bookmark and Share
PDF+Word+Text
Download of US
Patent 4171366
Bulk Download
of 50+ Related
Patent PDFs
$39.95
Document Number
US Patent 4171366
Issued Date
October 16, 1979
Link
Inventors
Map
Abstract
The present invention provides imidazole derivatives of the formula I ##STR1## wherein Het represents 1H-imidazol-1-yl which is unsubstituted or is substituted by lower alkyl, One of the symbols X and Y represents the epithio radical -S- or the ethenylene group --CH.dbd.CH--, and the other represents the direct bond, and N represents 1 to 4, And the rings A and B, besides being substituted by the radical -C.sub.n H.sub.2n -Het, are not substituted or are further substituted, and the ring C is unsubstituted or substituted, and the monoacid acid addition salts, in particular the pharmaceutically acceptable monoacid acid addition salts thereof. These new substances possess valuable pharmacological properties, in particular antidepressant activity, and can be used for the treatment of mental depressions. Specific embodiments are 1-[(naphtho[1,2-b]thien-4-yl)-methyl]-1H-imidazole and its pharmaceutically acceptable monoacid acid addition salts, and pharmaceutical compositions containing them.
Drawing
1-Naphthothienylalkyl-1H-imidazoles - US Patent 4171366 Drawing
Drawing from US Patent 4171366
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
16
Comments:
no comments yet
Owner
Published
October 16, 1979
Application Number
05/854,935
Filed
November 25, 1977
US Classification
514/397   548/311.4 548/311.7 548/335.1 548/346.1
Int'l Classification
C07D   495/04   (20060101)   C07D   521/00   (20060101)   C07D   333/00   (20060101)   C07D   333/74   (20060101)   C07D   333/34   (20060101)   C07D   333/24   (20060101)   C07D   495/00   (20060101)  
Examiner
Assistant Examiner
Attorney/Law Firm
Priority Data
Dec 01, 1976 [LU] 76303
USPTO Field of Search
548/336   424/273R  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us